Effects of almond on cardiometabolic outcomes in patients with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials

Author:

Moosavian Seyedeh Parisa1ORCID,Rahimlou Mehran2,Rezaei Kelishadi Mahnaz3ORCID,Moradi Sajjad4ORCID,Jalili Cyrus5ORCID

Affiliation:

1. Department of Community Nutrition, School of Nutrition and Food Sciences Shiraz University of Medical Sciences Shiraz Iran

2. Department of Nutrition, School of Medicine Zanjan University of Medical Sciences Zanjan Iran

3. Department of Community Nutrition, School of Nutrition and Food Science Isfahan University of Medical Sciences Isfahan Iran

4. Nutritional Sciences Department, School of Nutritional Sciences and Food Technology Kermanshah University of Medical Sciences Kermanshah Iran

5. Medical Biology Research Center, Health Technology Institute Kermanshah University of Medical Sciences Kermanshah Iran

Abstract

AbstractAn enhanced risk for cardiovascular disease (CVD) still exists even when T2DM patients have tight control on blood sugar. Thus, identification of treatment approaches that address CVD risk factors may be useful for patients beyond the blood sugar management. Although emerging evidence suggests that nuts consumption have beneficial effects on cardiometabolic health, the effects of almond intake in patients with type 2 diabetes are still controversial. Therefore, our objective was to investigate the effect of almond on cardiometabolic outcomes in patients with T2DM through a systematic review and meta‐analysis of available randomized controlled trials (RCTs). A systematic search was conducted in PubMed, Web of Science, Scopus, Embase, and Google Scholar to identify relevant RCTs up to March 2021. There was no language and time limitation. Weighted mean difference (WMD) was pooled using a random effects model. Heterogeneity, sensitivity analysis, and publication bias were reported using standard methods. Nine RCTs were included in the final analysis. Almond intake resulted in significant reduction in low‐density lipoprotein cholesterol (LDL‐C) (WMD: −5.28 mg/dL; 95% CI, −9.92, −0.64; p = .026) compared with the control group. This lowering effect of LDL‐C was robust in subgroups with almond consumption >50 g/day, and baseline LDL‐C level <130 mg/dL. However, the effect of almond on total cholesterol, triglycerides, high‐density lipoprotein cholesterol, fasting plasma glucose, insulin, hemoglobin A1c, body mass index, weight, body fat, systolic and diastolic blood pressure, and CRP was not significant compared with the control group. In summary, the current meta‐analysis indicated that almond consumption decreased LDL‐C, and had no favorable effect on other cardiometabolic outcomes in patients with T2DM. However, further high‐quality studies are needed to firmly establish the clinical efficacy of the almond.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.7亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3